$21.06
-0.41-1.91%
Fulgent Genetics Inc
FLGTNASDAQ
Fulgent Genetics (FLGT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Fulgent Genetics (FLGT) last issued guidance on July 30, 2026 for fiscal year 2026. The company guided earnings per share in the range of $-2.35 - $-2.22, compared to a consensus EPS estimate of $-1.82. Fulgent Genetics also guided revenue in the range of $330M - $340M for the period.
Compared to prior guidance, Fulgent Genetics lowered its EPS outlook from a previous range of $-1.59 - $-1.59. On the revenue side, the company lowered its revenue forecast from a prior range of $350M - $350M.
Fulgent Genetics has issued 20 guidance updates between November 7, 2022 and July 30, 2026. During this period, the company raised its outlook 9 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.51 | $-0.38 | $-0.09 | $-0.36 |
| Actual | $-0.58 | $-0.36 | $0.16 | $0.14 |
| Surprise | -13.7% | +5.26% | +277.8% | +138.9% |
| Revenue | ||||
| Estimate | $92.2M | $68.2M | $85.4M | $81.4M |
| Actual | $85.4M | $71.1M | $83.3M | $84.1M |
| Surprise | -7.40% | +4.38% | -2.39% | +3.33% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.72 | $-0.75 | $-0.85 | $-0.56 |
| Revenue | ||||
| Consensus | $86.3M | $88.9M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $-0.58 | $-0.51 | -13.7 % |
| Q1 | May 1, 2026 | $-0.36 | $-0.38 | 5.26 % |
| Q4 | Feb 27, 2026 | $0.16 | $-0.09 | 277.8 % |
| Q3 | Nov 7, 2025 | $0.14 | $-0.36 | 138.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $85.39M | $92.21M | -7.40 % |
| Q1 | May 1, 2026 | $71.14M | $68.15M | 4.38 % |
| Q4 | Feb 27, 2026 | $83.34M | $85.38M | -2.39 % |
| Q3 | Nov 7, 2025 | $84.07M | $81.36M | 3.33 % |
